NCT05177770 Study of SRF617 With AB928 (Etrumadenant) and AB122 (Zimberelimab) in Patients With Metastatic Castration Resistant Prostate Cancer Status TERMINATED Phase PHASE2
NCT05176756 RCT of Strategies to Augment Physical Activity in Black and Hispanic Breast and Prostate Cancer Survivors (ALLSTAR) Status COMPLETED Phase NA
NCT05172986 Enhanced Recovery Program After a Robotic-assisted Surgery (RAAC) of Radical Prostatectomy. PROSTA-RAAC Status COMPLETED Phase NA
NCT05171387 Darolutamide + Androgen Deprivation Therapy (ADT) in Chinese Men With High Risk, Nonmetastatic Prostate Cancer Status COMPLETED Phase PHASE2
NCT05169970 A Study of Stereotactic Body Radiation Therapy (SBRT) Without Androgen Deprivation Therapy (ADT) in People With Unfavorable Intermediate-Risk Prostate Cancer Status RECRUITING Phase PHASE2
NCT05169372 Retrospective Analysis of 68Ga-PSMA-PET in Patients With Prostate Cancer: Experience From Brazil Status TERMINATED Phase N/A
NCT05169112 Impact of Hormonal Therapy on Prostate Cancer Recurrence After Radical Prostatectomy Status RECRUITING Phase PHASE3
NCT05167175 The Study of Olaparib Combined With Abiraterone and Prednisone in mHSPC Patients With HRR Gene Mutation Status UNKNOWN Phase PHASE2
NCT05163197 Transperineal Laser Ablation Treatment (TPLA) for Prostate Cancer (PCa) Registry Status RECRUITING Phase N/A
NCT05161728 PSMA Response in Metastasized Hormone Sensitive Prostate Cancer Status RECRUITING Phase NA
NCT05160480 A Pilot Study of Total-body PET Using FDA-approved Radiotracers Beyond 18F-FDG Status ENROLLING_BY_INVITATION Phase N/A
NCT05156424 A Comparison of Aerobic and Resistance Exercise to Counteract Treatment Side Effects in Men With Prostate Cancer Status UNKNOWN Phase PHASE1/PHASE2
NCT05155618 Intervention Study in Prostate Cancer Patients Undergoing Radiotherapy Status ACTIVE_NOT_RECRUITING Phase NA
NCT05154162 PSMA PET Additive Value for Prostate Cancer Diagnosis in Men With Negative/Equivocal MRI Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05150236 EVOLUTION: 177Lu-PSMA Therapy Versus 177Lu-PSMA in Combination With Ipilimumab and Nivolumab for Men With mCRPC Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05146973 External Beam Therapy With Theranostic Radioligand Therapy for Oligometastatic Prostate Cancer (ProstACT TARGET) Status COMPLETED Phase PHASE2
NCT05146297 Diversity and Inclusion in Research Underpinning Prevention and Therapy Trials Status COMPLETED Phase NA